FDA Approves First-Ever Gene Therapy For Deafness, Opening Door To New Era

Miles, age 2, is one of the first patients at Boston Children’s hospital to receive gene therapy for hereditary hearing loss. He is now responding to his parents’ voices.

Joseph Piselli, Boston Children’s Hospital